This information is for people in the UK and Republic of Ireland who are prescribed Dupixent® (dupilumab).

You are viewing information about for caregivers

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the national reporting systems below:

In the UK

Through the national MHRA Yellow
Card scheme reporting system
www.mhra.gov.uk/yellowcard

Health information contained herein is provided for general educational purposes only. Please consult your healthcare professional if you have any questions about your health or treatment

The contents of this website have been developed and funded by Sanofi and Regeneron

MAT-XU-2303364 (v2.0)

Date of preparation: February 2024

Third-party disclaimer

You are now leaving the www.dupixentmyway.co.uk website

By clicking on “Continue” below, you will be leaving this Sanofi-hosted website, and, depending on the link, will be redirected to either another Sanofi website (for example, to view the Sanofi Privacy Policy) or an independent third-party website.

Sanofi has no control over the content or availability of third-party sites or resources that are linked to, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. The existence of a link between this website and any third-party site or resource in no way implies that Sanofi in any way approves of the content of these sites or resources, or any use to which such content may be put.

Please ensure that you read the legal and privacy policy sections of any website to which you link.


By clicking on the "Continue" button below you acknowledge that you have read this notice.